Keith John Kowalczyk, MD| Urologic Oncology, Urology | MedStar Health
Keith John Kowalczyk

Keith John Kowalczyk, MD
Provider is directly employed by MedStar Health

4.9 out of 5 (1721 reviews)

Specialties: Urologic Oncology, Urology

Languages: English

877-625-1478

About me

Keith Kowalczyk, MD, is the Physician Executive Director, MedStar Health Urology and the Chair, Department of Urology at MedStar Georgetown University Hospital. He is board certified in urology, with training in urologic oncology and robotic-assisted surgery. He sees patients at MedStar's Pasquerilla Healthcare Center at MedStar Georgetown in Washington, D.C., as well as MedStar's clinic in Chevy Chase.

Dr. Kowalczyk treats a full range of urologic conditions, but focuses on kidney, testicular, bladder, and prostate cancers. While skilled in performing traditional open surgery, his special expertise is in robotic-assisted surgery, and he has performed hundreds of procedures using this technology.

Dr. Kowalczyk is one of the few urologic surgeons in the D.C. metro area with specific expertise and training in urologic robotic surgery for urologic cancers. For those not familiar with robotic surgery, the surgeon uses special instruments controlled through a robotic/computer console which allows increased range of motion and often more precision than traditional surgical instruments. The camera he uses provides 10 to 12 times more magnification than traditional cameras used in surgery.

With his experience in performing robotic surgery, Dr. Kowalczyk is able to perform a more precise surgery with generally fewer complications. Also, Dr. Kowalczyk is able to offer more options for certain high-risk patients, like obese men who need prostatectomy surgery as well as patients with large kidney masses who have been told their kidney requires removal. With the magnified view and precision of robotic surgery, these patients have the options of minimally invasive procedures and better outcomes.

Dr. Kowalczyk is also actively involved in health services research on cancer treatments, outcomes, and patterns and costs of care and has authored numerous peer-reviewed articles on these topics.

Clinical areas of focus

  • Advanced Prostate Cancer
  • Bladder Cancer
  • Bladder Cancer Treatment
  • Robotic Prostatectomy
Show More

Conditions and procedures

Conditions I treat

  • Adrenal Tumor
  • Advanced Prostate Cancer
  • Bladder Cancer
  • Bladder Carcinoma
  • Congenital Obstructive Defects Of Renal Pelvis
  • Elevated Psa Levels
  • Genitourinary Sarcoma
  • Kidney Blockage
  • Kidney Cancer
  • Malignant Neoplasm Of Renal Pelvis
  • Malignant Neoplasm Of Ureter
  • Penile Cancer
  • Prostate Cancer
  • Submandibular Gland Cancer
  • Testicular Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
Show All Show Less

Procedures I perform

  • Bladder Cancer
  • Bladder Cancer Treatment
  • Da Vinci Gastrectomy
  • Kidney Cancer
  • Penile Cancer
  • Prostate Cancer
  • Psa Testing
  • Robotic Prostatectomy
  • Testicular Cancer
Show All button Press enter to expand Show Less

Practice locations

Distance from Change LocationEnter your Location

25500 Point Lookout Rd
2nd Fl
Leonardtown, MD, 20650

202-444-4922

Fax 877-625-1478

Get Directions

miles away

Fax 877-625-1478

3800 Reservoir Rd NW
HealthCare Center 3rd Fl
Washington, DC, 20007

202-444-4922

Fax 877-625-1478

Get Directions

miles away

Fax 877-625-1478

5530 Wisconsin Ave
Ste 950
Chevy Chase, MD, 20815

301-652-7872

Fax 877-625-1478

Get Directions

miles away

Fax 877-625-1478

18101 Prince Philip Dr
Ste 368
Olney, MD, 20832

202-444-4922

Fax 877-625-1478

Get Directions

miles away

Fax 877-625-1478

Insurance

MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.

  • List of insurance plans we accept
    • Erickson Advantage Plans
    • Veterans Affairs Community Care Network
    • Aetna Quality Point of Service (POS)
    • CareFirst Maryland Point of Service Plan
    • Kaiser Permanente Select
    • Choice POS
    • Blue Choice Advantage
    • CareFirst FEP Blue Focus
    • Options PPO Cardiac Global
    • Medicare Advantage - Advantra Value (PPO)
    • First Health PPO
    • Aetna Open Choice (PPO)
    • CareFirst (NCA) Indemnity
    • Kaiser Permanente Medicare Advantage Signature and Select
    • BlueChoice Open Access
    • M.D. IPA Preferred (POS)
    • Jai Medical Systems - Maryland Health Choice
    • CIGNA HMO Open Access
    • Aetna Better Health of MD
    • Aetna Worker's Compensation Network
    • Cigna True Choice Plus Medicare (PPO)
    • Mamsi Life & Health (Indem./PPO) Cardiac Global
    • CareFirst Federal Employee Program (Std. & Basic PPO)
    • Aetna Advantage 6350
    • CIGNA HMO & Network (HMO)
    • CareFirst BlueChoice HMO
    • Optima Family Care MCO - VA Medicaid MCO
    • Aetna Signature Administrator PPO/TPA
    • United Healthcare Navigate Cardiac Global
    • CareFirst Blue Card Program
    • CareFirst Group Medicare Advantage
    • Kaiser Permanente Flexible Choice POS Cardiac Global
    • TriWest Healthcare Alliance
    • Aetna Medicare Advantage PFFS Plan
    • Navigate
    • POS OA
    • UnitedHealthcare Medicare Adv. Special Needs Plans
    • Anthem BCBS of VA HealthKeepers (HMO)
    • United Healthcare Choice
    • HUMANA/Choice Care Medicare Plans (Choice, Gold Choice)
    • Private Health Care Systems (PPO)
    • Aetna Managed Choice (POS)
    • United Healthcare Choice Plus Cardiac Global
    • United Medicare Private Fee-for-Service (PFFS) plans
    • TRICARE East Prime
    • Kaiser Permanente Medicare Plus
    • AMERIVANTAGE/Amerigroup Community Care
    • CareFirst Community Health Plan of MD
    • Cigna Achieve Medicare (HMO C-SNP)
    • Priority Partners - Maryland Health Choice
    • AmeriHealth Caritas DC Healthy Families
    • United Healthcare Choice Cardiac Global
    • Coventry Health Care National Network PPO
    • United HealthCare Community Plan - Maryland Health Choice Program
    • Amerigroup DC Healthy Families
    • BCBS Out-of-State Medicare Plans (Blue Advantage)
    • OCI Direct (HMO)
    • Advantra Platinum (PPO)
    • Aetna Advantage 6350PD
    • Geisinger Medicare Advantage
    • Kaiser Permanente Select Cardiac Global
    • Kaiser Permanente Signature - Added Choice
    • HumanaChoice Honor's plan PPO
    • First Health PPO
    • Aetna Classic 3500
    • Aetna Classic 5000
    • IH-Open EPO Plus
    • UHC Group Medicare Advantage Plans (HMO, POS, PPO)
    • Anthem Federal Employee Program Basic
    • Kaiser Permanente Flexible Choice 3-tier POS
    • Magellan Complete Care of VA - VA Medicaid MCO
    • United Healthcare Choice Plus
    • TRICARE East Select
    • Aetna Elect Choice/ EPO (Aetna Health Fund)
    • CIGNA Connect EPO
    • CareFirst Dual Prime HMO-SNP
    • CareFirst BlueCross BlueShield Advantage Core/Enhanced
    • MedStar Family Choice DC Healthy Families
    • United Healthcare Select HMO - EPO/NPP
    • Humana Medicare Advantage - HMO Open Access
    • Sentara Health
    • Amerigroup DC Alliance
    • Aetna HMO
    • Network OA
    • Cigna Preferred Medicare (HMO)
    • MedStar Family Choice DC Healthcare Alliance
    • CIGNA POS/Network POS
    • HealthyBlue PPO
    • CIGNA Indemnity
    • WellPoint Maryland - Maryland Health Choice
    • Aetna Advantage 5750
    • Anthem BCBS of VA HealthKeepers Plus
    • UnitedHealthcare and AARP Medicare Complete Plans
    • Kaiser Permanente HMO Plus and DHMO Plus Member
    • Healthy Blue (HMO, POS)
    • HighMark
    • UnitedHealthcare Medicare Advantage DSNP District of Columbia
    • Cigna Alliance Medicare (HMO)
    • CareFirst Administrators
    • Police and Fire Clinic
    • AmeriHealth Caritas DC Healthcare Alliance
    • Aetna VA Exchange
    • Choice Fund PPO
    • Uniformed Services Family Health Plan
    • Aetna Classic 5000PD
    • HumanaChoice PPO
    • IH-Open HMO
    • Core Essential (HMO)
    • United Healthcare Options (PPO)
    • Johns Hopkins Advantage MD PLUS PPO
    • IH-POS
    • Anthem Federal Employee Program Standard
    • UnitedHealthcare Individual Exchange Plans
    • Kaiser Maryland Medicaid MCO
    • CareFirst EPO
    • TRICARE for Life East
    • Aetna Better Health of VA
    • Humana Gold Plus HMO
    • Aetna Elect Choice/ Open Access (POS)
    • MedStar Family Choice DC Healthcare Alliance
    • Humana Medicare Advantage - PPO
    • CareFirst MedStar PPO
    • Kaiser Permanente Select - Added Choice
    • IH-Indemnity
    • Cigna True Choice Medicare (PPO)
    • Choice Care Network/HUMANA (PPO)
    • Medicare FFS
    • OA Plus
    • Aetna Managed Choice Open Access (POS)
    • CareFirst Blue Choice Opt Out Open Access
    • BCBS of Michigan (BCN Advantage,Security Blue, Freedom, Medicare PLUS Blue Group PPO)
    • MedStar Family Choice - Maryland Health Choice
    • Mamsi Life & Health (Indem./PPO)
    • CareFirst NASCO
    • IH-Open Network Only Plus
    • Anthem BCBS Medi Blue SNP
    • Medicare Direct
    • Choice POS II
    • Employee Health Plan
    • IH-PPO
    • Tricare Reserve Select
    • Fee-for-Service (FFS) District of Columbia, Maryland and Virginia Medicaid
    • M.D. IPA (HMO)
    • Optimum Choice Preferred (POS)
    • MultiPlan, Inc
    • Choice POS II Open Access
    • Maryland Physicians Care MCO
    • Anthem BCBS of VA Key Care POS/PPO/Indemnity
    • Johns Hopkins Advantage MD PPO
    • Aetna HMO-Open Access/Select OA/HealthFund/Health Network Option OA
    • CareFirst MedStar Select PPO
    • Anthem BCBS Medi Blue Dual Adv
    • Coventry Health Care of Virginia
    • United Healthcare Select Plus (POS)
    • Kaiser Permaenete Signature - Added Choice Cardiac Global
    • Fee-for-Service (FFS) District of Columbia, Maryland and Virginia Medicaid
    • IH-POS Plus
    • CareFirst Blue Preferred PPO
    • Aetna Student Health Insurance
    • UnitedHealthcare Individual Exchange Plans
    • Optimum Choice
    • DC/MD SHOP QHP Small Business Plans
    • CareFirst Group Medicare Advantage prescription drug benefit (PPO)
    • Lasso Healthcare - Medicare Medical Savings Account
    • CIGNA SureFit (HMO)
    • Cigna TotalCare (HMO D-SNP)
    • Health Services for Children with Special Needs
    • Aetna Traditional Choice (PPO)
    • IH-Open POS Plus
    • CIGNA PPO
    • Coventry of Delaware HMO/PPO
    • Alterwood Advanatge HMO & DSNP Plans
    • IH-Network Only Plus
    • Private Fee-for-Service Plans (PFFS)
    • CareFirst Blue Choice Opt Out Plus Open Access (POS)
    • CIGNA PPO Plus
    • United Student Resources
    • Beech Street PPO
    • Select HMO/HealthFund/Health Network
    • IH-Open HMO Option
    • Anthem BCBS of VA HealthKeepers (POS & POS OA)
    • Great-West Healthcare POS/CIGNA
    • MedStar Family Choice - Maryland Health Choice
    • Aetna Medicare Advantage HMO & PPO Plans
    • NYC Medicare Advantage Plus
    • Optimum Choice & Optimum Choice Preferred (POS) Cardiac Global
    • United Healthcare Community Plan - VA Medicaid MCO
    • UHC Passport
    • IH-Open POS II
    • Anthem BCBS Medi Blue Plus
    • United Healthcare Select HMO-EPO/NPP Cardiac Global
    • Aetna Premier 200PD
    • Johns Hopkins Advantage MD HMO
    • Kaiser Permanente Signature
    • Aetna Basic
    • IH-EPO Plus
    • CareFirst Maryland Indemnity or PPO
    • MD IPA (HMO) & MD IPA Preferred Cardiac Global
    • IH-HMO
    • CIGNA EPO
    • Mamsi Life & Health (Indem./PPO)

Videos

Education

Board Certification: American Board of Urology, Urology

Fellowship: Brigham and Women's Hospital (2011)

Residency: Georgetown University Hospital (2010)

Internship: Georgetown University Hospital (2006)

Medical School: Georgetown University (2005)

Awards

  • Faculty Teacher of the Year Award, Georgetown University/Washington Hospital Center Urology Residency Program (2015)
  • Resident Teacher Award, Department of Urology. Georgetown University Hospital (2010)
  • String of Pearls Finalist, Best Resident Teacher, Georgetown University Hospital (2010)
  • 3rd Place, Resident Research Presentation, Washington Urologic Society (2008)

News and publications

Complex space of Retzius lymphocele resulting in iliac compression and submassive pulmonary embolism after robotic Retzius sparing prostatectomy.  C Goldman, CP Dall, T Sholklapper, J Brems, K Kowalczyk.  Urology Case Reports, epub, 2021.

 

Retzius-Sparing Robot-Assisted Robotic Prostatectomy: Past, Present, and Future

M Davis, J Egan, S Marhamati, A Galfano, KJ Kowalczyk.  Urologic Clinics 48 (1), 11-23, 2021.

 

Impact of Retzius-sparing Versus Standard Robotic-assisted Radical Prostatectomy on Penile Shortening, Peyronie’s Disease, and Inguinal Hernia Sequelae.  KJ Kowalczyk, M Davis, J O’Neill, H Lee, J Orzel, RS Rubin, JC Hu.  European Urology Open Science 22, 17-22

 

Sex and Racial Disparities in the Treatment and Outcomes of Muscle-Invasive Bladder Cancer.  Marinaro J, Zeymo A, Carvalho F, Krasnow R, Egan JE, Stamatakis L, Lynch JH, Hwang J,

Williams SB, Kowalczyk KJ.  Urology, in press, 2020.

 

Retzius-sparing robot-assisted radical prostatectomy leads to durable improvement in urinary function and quality of life versus standard robot-assisted radical prostatectomy without compromise of oncologic efficacy:  single surgeon series and step-by-step guide.  Egan J, Marhamati S, Carvalho F, Davis M, O’Neill J, Lee H, Lynch JH, Hankins RA, Hu JC, Kowalczyk KJ.  European Urology, Epub ahead of print June 11 2020.

 

Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer.

Carvalho FL, Zeymo A, Egan J, Kelly CH, Zheng C, Lynch JH, Hwang J, Stamatakis L, Krasnow RE, Kowalczyk KJ. Investig Clin Urol, 61(4):390-396, July 2020

 

Prostate Cancer in Men With Treated Advanced Heart Failure: Should we Keep Screening?

Lee HH, Shaw NM, Mohammed S, Kowalczyk KJ, Stamatakis L, Krasnow RE.

Urology. 2020 Feb;136:46-50.

 

Complications associated with perioperative use of tyrosine kinase inhibitors and cytoreductive nephrectomy.  Carvalho FL, Zheng C, Witmer K, O’Neill J, Lynch JH, Krasnow R, Stamatakis L, Kowalczyk KJ.  Sci Rep. 2019 Oct 24;9(1):15272.

 

Fidelity of a PDX-CR model for bladder cancer.  Mondal AM, Ma AH, Li G, Krawczyk E, Yuan R, Lu J, Schlegel R, Stamatakis L, Kowalczyk KJ, Philips GK, Pan CX, Liu X. Biochem Biophys Res Commun. 2019 Sep 10;517(1):49-56

 

Survival and secondary interventions following treatment for locally-advanced prostate cancer.  Sussman R, Carvalho FL, Harbin A, Zheng C, Lynch JH, Stamatakis L, Hwang J, Williams SB, Hu JC, Kowalczyk KJ.  Canadian Journal of Urology, October 2018, 25 (5): 9425-9433.

 

Utilization and predictors of expectant management among elderly men with low-and intermediate-risk localized prostate cancer in U.S. urological practice.  Tsai HT, Philips G, Taylor KL, Kowalczyk KJ, Huai-Ching K, Potosky A.  Urol Pract. 2017 Mar;4(2):132-139

 

Giant renal oncocytoma with classic stellate scar. Sussman RD, Kowalczyk KJ.  BMJ Case Rep, Jan 2017, http://casereports.bmj.com/content/2017/bcr-2016-218944.

 

Transobturator sling for post-prostatectomy incontinence: radiation’s effect on efficacy and satisfaction.  Wright HC, McGeagh K, Richter LA, Hwang JJ, Venkatesen K, Pysher A, Koch GE, Kowalczyk KJ, Bandi G, Marchalik D. Canadian Journal of Urology 2017, 24 (5), 8998-9002.

 

Single-center, FDA approved, prospective evaluation of the safety and efficacy of PAE for LUTS from BPH.  Kim A, Kowalczyk KJ, Lynch J, Spies J.  Journal of Vascular and Interventional Radiology 2017, 2 (28), S115-S116.

 

Perioperative outcomes of robotic and laparoscopic simple prostatectomy: a European-American multi-institutional analysis.  Autorino R, Zargar H, Mariano MB, Kowalczyk KJ, et al.  European Urology.  July 2015 68:1: 86-94.

 

The burden of skeletal-related events in patients with prostate cancer and bone metastasis. Roghmann F, Antczak C, McKay RR, Choueiri T, Hu JC, Kibel AS, Kim SP, Kowalczyk KJ, Menon M, Nguyen PL, Saad F, Sammon JD, Schmid M, Sukumar S, Sun M, Noldus J, Trinh QD. Urol Oncol. 2015 Jan;33(1):17. e9-18.

 

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer.  Arscott WT, Chen LN, Wilson N, Bhagat A, Kim JS, Moures RA, Yung TM, Lei S, Collins BT, Kowalczyk K, Suy S, Dritschilo A, Lynch JH, Collins SP.  Radiat Oncol. 2014 Jul 24; 9:163

 

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.  Chen LN, Suy S, Wang H, Bhagat A, Woo JA, Moures RA, Kim JS, Yung TM, Lei S, Collins BT, Kowalczyk K, Dritschilo A, Lynch JH, Collins SP.  Radiat Oncol. 2014 Jun 26; 9:148

 

Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies.  Chen LN, Rubin RS, Othepa E, Cer C, Yun E, Agarwal RP, Collins BT, McGeagh K, Pahira J, Bandi G, Kowalczyk K, Kumar D, Dritschilo A, Collins SP, Bostwick DG, Lynch JH, Suy S.  Prostate. 2014 May;74(7):714-21.

 

Multi-institutional outcomes and cost effectiveness of using alvimopan to lower gastrointestinal morbidity after cystectomy and urinary diversion.  Vora A, Marchalik D, Nissim H, Kowalczyk K, Bandi G, McGeagh K, Lynch J, Venkatesan K, Ghasemian R, Hwang J, Hwang MV.  Can J Urol. 2014 Apr;21(2):7222-7

 

Is there any evidence of a "July effect" in patients undergoing major cancer surgery?

Ravi P, Trinh VQ, Sun M, Sammon J, Sukumar S, Gervais MK, Shariat SF, Kim SP, Kowalczyk KJ, Hu JC, Menon M, Karakiewicz PI, Trinh QD. Can J Surg. 2014 Apr;57(2):82-8.

 

Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer. Kowalczyk KJ, Gu X, Nguyen PL, Lipsitz SR, Trinh QD, Lynch JH, Collins SP, Hu JC. Urol Oncol. 2014 Apr;32(3):303-8. doi: 10.1016/j.urolonc.2013.09.004.

 

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer.  Bhattasali O, Chen LN, Woo J, Park JW, Kim JS, Moures R, Yung T, Lei S, Collins BT, Kowalczyk K, Suy S, Dritschilo A, Lynch JH, Collins SP.  Radiat Oncol. 2014 Feb 11; 9:52.

 

 Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. Trinh VQ, Karakiewicz PI, Sammon J, Sun M, Sukumar S, Gervais MK, Shariat SF, Tian Z, Kim SP, Kowalczyk KJ, Hu JC, Menon M, Trinh QD. JAMA Surg. 2014 Jan;149(1):43-9.

 

Potency preservation following stereotactic body radiation therapy for prostate cancer.  Obayomi-Davies O, Chen LN, Bhagat A, Wright HC, Uhm S, Kim JS, Yung TM, Lei S, Batipps GP, Pahira J, McGeagh KG, Collins BT, Kowalczyk K, Bandi G, Kumar D, Suy S, Dritschilo A, Lynch JH, Collins SP.  Radiat Oncol. 2013 Nov 1; 8:256

 

Robotic-assisted prostatectomy and open radical retropubic prostatectomy for locally-advanced prostate cancer: multi-institution comparison of oncologic outcomes. Vora AA, Marchalik D, Kowalczyk KJ, Nissim H, Bandi G, McGeagh KG, Lynch JH, Ghasemian SR, Verghese M, Venkatesan K, Borges P, Uchio EM, Hwang JJ. Prostate Int. 2013;1(1):31-6.

 

Incidence and treatment patterns in males presenting with lower urinary tract symptoms to the emergency department in the United States. Roghmann F, Ghani KR, Kowalczyk KJ, Bhojani N, Sammon JD, Gandaglia G, Trudeau V, Becker A, Sukumar S, Menon M, Zorn KC, Karakiewicz P, Sun M, Noldus J, Trinh QD. J Urol. 2013 Nov;190(5):1798-804.

 

 Use of surveillance imaging following treatment of small renal masses.

Kowalczyk KJ, Harbin AC, Choueiri TK, Hevelone ND, Lipsitz SR, Trinh QD, Tina Shih YC, Hu JC. J Urol. 2013 Nov;190(5):1680-5. doi: 10.1016/j.juro.2013.05.109.

 

Predictors of Gleason score upgrading in a large African-American population.  Vora A, Large T, Aronica J, Haynes S, Harbin A, Marchalik D, Nissim H, Lynch J, Bandi G, McGeagh K, Kowalczyk K, Ghasemian R, Venkatesan K, Verghese M, Hwang J.  Int Urol Nephrol. 2013 Oct;45(5):1257-62

 

Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy. Kaplan JR, Kowalczyk KJ, Borza T, Gu X, Lipsitz SR, Nguyen PL, Friedlander DF, Trinh QD, Hu JC.  BJU Int. 2013 Jun;111(8):1208-14.

 

Health care-associated infections after major cancer surgery: temporal trends, patterns of care, and effect on mortality. Sammon J, Trinh VQ, Ravi P, Sukumar S, Gervais MK, Shariat SF, Larouche A, Tian Z, Kim SP,Kowalczyk KJ, Hu JC, Menon M, Karakiewicz PI, Trinh QD, Sun M. Cancer. 2013 Jun 15;119(12):2317-24.

 

The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy. Trinh QD, Sun M, Kim SP, Sammon J, Kowalczyk KJ, Friedman AA, Sukumar S, Ravi P, Muhletaler F, Agarwal PK, Shariat SF, Hu JC, Menon M, Karakiewicz PI. Urol Oncol. 2014 Jan;32(1):29. e13-20.

 

Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007. Kowalczyk KJ, Choueiri TK, Hevelone ND, Trinh QD, Lipsitz SR, Nguyen PL, Lynch JH, Hu JC. BJU Int. 2013 Aug;112(4): E273-80.

 

 

 Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States. Sammon JD, Ghani KR, Karakiewicz PI, Bhojani N, Ravi P, Sun M, Sukumar S, Trinh VQ,Kowalczyk KJ, Kim SP, Peabody JO, Menon M, Trinh QD. Eur Urol. 2013 Jul;64(1):85-92.

 

 

Effect of minimizing tension during robotic-assisted laparoscopic radical prostatectomy on urinary function recovery. Kowalczyk KJ, Huang AC, Hevelone ND, Lipsitz SR, Yu HY, Lynch JH, Hu JC. World J Urol. 2013 Jun;31(3):515-21.

 

Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.  Chen LN, Suy S, Uhm S, Oermann EK, Ju AW, Chen V, Hanscom HN, Laing S, Kim JS, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Dawson NA, Taylor KL, Dritschilo A, Lynch JH, Collins SP.  Radiat Oncol. 2013 Mar 13; 8:58.

 

Anatomic and technical considerations for optimizing recovery of urinary function during robotic-assisted radical prostatectomy. Vora AA, Dajani D, Lynch JH, Kowalczyk KJ.

Curr Opin Urol. 2013 Jan;23(1):78-87.

 

Influence of surgeon and hospital volume on radical prostatectomy costs.

Williams SB, Amarasekera CA, Gu X, Lipsitz SR, Nguyen PL, Hevelone ND, Kowalczyk KJ, Hu JC. J Urol. 2012 Dec;188(6):2198-202.

 

Factors associated with the adoption of minimally invasive radical prostatectomy in the United States. Ulmer WD, Prasad SM, Kowalczyk KJ, Gu X, Dodgion C, Lipsitz S, Palapattu GS, Choueiri TK, Hu JC. J Urol. 2012 Sep;188(3):775-80.

 

Morbidity and costs of salvage vs. primary radical prostatectomy in older men.  Prasad SM, Gu X, Kowalczyk KJ, Lipsitz SR, Nguyen PL, Hu JC. Urol Oncol. 2013 Nov;31(8):1477-82.

 

Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Yu HY, Hevelone ND, Lipsitz SR, Kowalczyk KJ, Nguyen PL, Choueiri TK, Kibel AS, Hu JC.  Eur Urol. 2012 Jun;61(6):1239-44.

 

Technical refinement and learning curve for attenuating neurapraxia during robotic-assisted radical prostatectomy to improve sexual function.

Alemozaffar M, Duclos A, Hevelone ND, Lipsitz SR, Borza T, Yu HY, Kowalczyk KJ, Hu JC. Eur Urol. 2012 Jun;61(6):1222-8. 

 

Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy. Yu HY, Hevelone ND, Lipsitz SR, Kowalczyk KJ, Nguyen PL, Hu JC.

J Urol. 2012 May;187(5):1632-7.

 

Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery. Yu HY, Hevelone ND, Lipsitz SR, Kowalczyk KJ, Hu JC.J Urol. 2012 Apr;187(4):1392-8.

 

Temporal national trends of minimally invasive and retropubic radical prostatectomy outcomes from 2003 to 2007: results from the 100% Medicare sample. Kowalczyk KJ, Levy JM, Caplan CF, Lipsitz SR, Yu HY, Gu X, Hu JC. Eur Urol. 2012 Apr;61(4):803-9.

 

Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer.

Williams SB, Lei Y, Nguyen PL, Gu X, Lipsitz SR, Yu HY, Kowalczyk KJ, Hu JC.

BJU Int. 2012 Jul;110(2 Pt 2):E92-8.

 

Partial clamping of the renal artery during robot-assisted laparoscopic partial nephrectomy: technique and initial outcomes. Kowalczyk KJ, Alemozaffar M, Hevelone ND, Ulmer WD, Plaster BA, Lipsitz SR, Yu HY, Hu JC. J Endourol. 2012 May;26(5):469-73.

 

Comparison of outpatient narcotic prescribing patterns after minimally invasive versus retropubic and perineal radical prostatectomy. Kowalczyk KJ, Weinburg AC, Gu X, Yu HY, Lipsitz SR, Williams SB, Hu JC. J Urol. 2011 Nov;186(5):1843-8.

 

Stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: technique and outcomes. Kowalczyk KJ, Huang AC, Hevelone ND, Lipsitz SR, Yu HY, Ulmer WD, Kaplan JR, Patel S, Nguyen PL, Hu JC.

Eur Urol. 2011 Sep;60(3):536-47.

 

Challenges of interpreting and improving radical prostatectomy outcomes: technique, technology, training, and tactical reporting. Hu JC, Yu HY, Kowalczyk KJ.

Eur Urol. 2011 Jun;59(6):1073-4.

 

Outcomes assessment in men undergoing open retropubic radical prostatectomy, laparoscopic radical prostatectomy, and robotic-assisted radical prostatectomy. Kowalczyk KJ, Yu HY, Ulmer W, Williams SB, Hu JC. World J Urol. 2012 Feb;30(1):85-9.

 

Health services research in urology. Yu HY, Ulmer W, Kowalczyk KJ, Hu JC. World J Urol. 2011 Jun;29(3):273-6.

 

The impact of prostate size, median lobe, and prior benign prostatic hyperplasia intervention on robot-assisted laparoscopic prostatectomy: technique and outcomes. Huang AC, Kowalczyk KJ, Hevelone ND, Lipsitz SR, Yu HY, Plaster BA, Amarasekara CA, Ulmer WD, Lei Y, Williams SB, Hu JC. Eur Urol. 2011 Apr;59(4):595-603.

 

Athermal division and selective suture ligation of the dorsal vein complex during robot-assisted laparoscopic radical prostatectomy: description of technique and outcomes.

Lei Y, Alemozaffar M, Williams SB, Hevelone N, Lipsitz SR, Plaster BA, Amarasekera CA, Ulmer WD, Huang AC, Kowalczyk KJ, Hu JC. Eur Urol. 2011 Feb;59(2):235-43.

 

Partial nephrectomy after previous radio frequency ablation: The National Cancer Institute experience. Kowalczyk KJ, Hooper HB, Linehan WM, Pinto PA, Wood BJ, Bratslavsky G. J Urol. 2009 Nov;182(5):2158-63.

 

Abstracts

 

Retzius-Sparing Robotic Radical Prostatectomy Shortened Recovery of Patient Continence Without Compromise of Oncologic Outcomes.  O’Neill JW, Carvalho F, Lee H, Egan J, Shaw N, Lynch JH, Holzman S, Witmer K, Wright HC, Kowalczyk KJ.  Accepted, Podium Presentation, MAAUA Annual Meeting, Pocono Manor PA, October 2019.
 

Gender and racial disparities in the treatment and outcomes of muscle invasive bladder cancer.  Marinaro J, Egan J, Carvalho F, Zeymo A, Stamatakis L, Krasnow R, Kowalczyk KJ.  Accepted, Resident Prize Essay Podium Presentation, MAAUA Annual Meeting, Pocono Manor PA, October 2019.
 

Delays from diagnosis to radical cystectomy are associated with worse survival in muscle-invasive bladder cancer.  Carvalho F, Zeymo A, Shaw N, Egan J, Stamatakis L, Krasnow RE, Lynch JH, Kowalczyk KJ.  Accepted, Podium Presentation, MAAUA Annual Meeting, Pocono Manor PA, October 2019.
 

Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer: results from the National Cancer Database.  Carvalho F, Kelly C, Zeymo A, Zheng C, Stamatakis L, Krasnow R, Kowalczyk KJ.  Resident Prize Essay, 3rd Prize, MAAUA Annual Meeting, Washington DC, October 2018.

 

The Decipher Prostate Cancer classifier correlates with CAPRA-S in a high-risk group of African-American and Caucasian Patients. Alger J, Beamer M, Gadalla R, Nissim H, Stamatakis L, Krasnow R, Kowalczyk KJ, Hwang J.  AUA Annual Meeting, San Francisco CA, May 2018.

 

Metabolic biomarkers are predictive of response to radiation therapy in prostate cancer patients. Cheema A, Grindrod S, Suy S, Zhong X, Jain S, Mehta K, Bandi G, Kowalczyk KJ, Lynch J, Collins S, Dritschilo A. AUA Annual Meeting, San Francisco CA, May 2018.

 

Complications associated with post-nephrectomy tyrosine kinase inhibitor use: results from SEER-Medicare.  Carvalho FL, Zheng C, Witmer K, Jeng S, O’Neill J, Lynch JH, Kowalczyk KJ.  AUA National Meeting, San Diego CA, May 2016

 

Outcomes and costs following treatment for locally advanced prostate cancer: Results from SEER-Medicare. Sussman R, Harbin A, Lynch J, Hu JC, Kowalczyk KJ.  AUA National Meeting, New Orleans LA, 2015

 

Secondary Interventions After Treatment for Locally Advanced Prostate Cancer. Sussman R, Harbin A, Lynch J, Hu JC, Kowalczyk KJ.    MAAUA Annual Meeting, Baltimore MD, 2014

 

Trends in treatment for men with clinically high-risk prostate cancer from 1995-2007: Results from SEER-Medicare.  Harbin A, Sussman R, Lynch J, Hu JC, Kowalczyk KJ.  AUA Annual Meeting, Orlando FL, 2014

 

Multi-institutional Predictors of Gleason Score Upgrading in a Large African-American Population. Vora AA, Large T, Aronica J, Haynes S, Harbin AC, Marchalik D, Nissim H, Lynch JH, Bandi G, McGeagh KM, Kowalczyk KJ, Ghasemian SR, Venkatesen K, Verghese M, Hwang JJ.  AUA Annual Meeting, San Diego CA, May 2013.

 

Correlation of Prognostic Molecular Markers (ERG expression, PTEN delation, and HOXD3 promotor hypermethylation) with Clinical and Pathologic Features in Screening Prostate Biopsies.  Rubin R, Chen L, Bandi G, McGeagh K, Pahira H, Collins S, Suy S, Kowalczyk KJ, Lynch JH.  AUA Annual Meeting, San Diego CA, May 2013.

 

Multi-institutional Outcomes and Cost-Effectiveness of Using Alvimopan to Lower GI Morbidity After Cystectomy and Urinary Diversion.  Vora AA, Rayson R, Harbin AC, Bandi G, McGeagh KM, Kowalczyk KJ, Lynch JH, Ghasemian SR, Venkatesen K, Hwang JJ, Verghes M.  AUA Annual Meeting, San Diego CA, May 2013.

 

Optimal timing of early vs. delayed adjuvant radiation therapy for locally advanced prostate cancer.  Kowalczyk KJ, Gu X, Nguyen PL, Lipsitz SR, Yu HY, Collins SP, Hu JC.    AUA Annual Meeting, Atlanta GA, May 2012.

Radiotherapy following prostatectomy does not impact bone-related events in patients with node-positive prostate cancer.  Kaplan J, Kowalczyk KJ, Borza T, Gu X, Nguyen PL, Yu HY, Hu JCAUA Annual Meeting, Atlanta GA, May 2012.

Influence of Surgeon and Hospital Volume on Radical Prostatectomy Costs.  Kowalczyk KJ, Williams SB, Amarasekara CA, Gu X, Lipsitz SR, Nguyen PL, Hu JC.  New England and Mid-Atlantic AUA Joint Annual Meeting, Orlando FL, 2011.

 

The Impact of Prostate Size, Median Lobe, and Prior Benign Prostatic Hyperplasia Intervention on Robotic-Assisted Radical Prostatectomy: Technique and Outcomes.  Kowalczyk KJ, Huang AC, Hevelone ND, Lipsitz SR, Yu HY, Plaster BA, Amarasekara CA, Ulmer WD, Williams SB, Hu JC.  New England and Mid-Atlantic AUA Joint Annual Meeting, Orlando FL, 2011.

 

Adjuvant vs. Salvage Radiation Therapy Following Prostatectomy for Locally Advanced Prostate Cancer: Results from SEER-Medicare.  Kowalczyk KJ, Gu X, Yu H, Nguyen PL, Hu JC.  AUA Annual Meeting, Washington DC, 2011.

 

Robotic-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy for Locally Advanced Prostate Cancer: A Comparison of Oncologic Outcomes. Kowalczyk KJ, Vora AA, Christiansen KA, Nissim H, Lynch JH, Ghasemian SR, Verghese M, Uchio E, Hwang JJ.  MAAUA Annual Meeting, Nemacolin PA, 2010.

 

The Transobturator Male Sling for Post-Prostatectomy Incontinence: A Single-Institution's Initial Experience.  Kowalczyk KJ, Laviana AA, Richter LA, Hwang JJ, Lynch JH, McGeagh KG.  MAAUA Annual Meeting, Nemacolin PA, 2010.

 

Improving Urinary Continence in Robotic Prostatectomy: A Novel Urethral Plate Suspension Suturing (UPSS) Technique.  Hwang JJ, Stisser B, Kowalczyk KJ, Ghasemian SR, Lynch JH, McGeagh KG, Verghese M, Uchio E.  MAAUA Annual Meeting, Nemacolin PA, 2010.

 

Robotic-Assisted Laparoscopic Prostatectomy for Locally Advanced Prostate Cancer.  Kowalczyk KJ, Vora AA, Christiansen KA, Lynch JH, Ghasemian SR, and Hwang JJ.  Society of Urologic Oncology Annual Meeting, Bethesda MD, 2009.

 

Robotic Assisted Laparoscopic Partial Nephrectomy: A Review of Surgical Outcomes from a Single Institution's Initial Experience.  Christiansen KA, Kowalczyk KJ, Lynch JH, Verghese M, Ghasemian SR, and Hwang JJ. MAAUA Annual Meeting, Williamsburg VA, 2009.

 

Routine Ureteral Frozen Section Examination at The Time of Radical Cystectomy: Utility and Cost-Effectiveness.  Kowalczyk KJ, Christiansen KA, Lynch JH, Verghese M, Ghasemian SR, and Hwang JJ.    AUA Annual Meeting, Chicago IL, 2009.

 

Ureteral Frozen Section At The Time Of Radical Cystectomy: Is It Always Necessary?  Kowalczyk KJ, Verghese M, Ghasemian SR, and Hwang JJ.  MAAUA Annual Meeting, Columbia MD, 2008.

 

Outcomes of Partial Nephrectomy after Previous Radiofrequency Ablation: The NCI Experience.  Kowalczyk KJ, Hooper HB, Linehan WM, Wood BJ, Pinto PA, and Bratslavsky G.     AUA Annual Meeting, Orlando FL, 2008.

 

Video Abstracts

 

Hemorrhagic Complications of Laparoscopic and Robotic Renal and Adrenal Surgery: When to Convert.  Liu N, Khurana K, Kowalczyk KJ, Hooper HB, Bratslavsky G, and Pinto PA.  AUA Annual Meeting, Orlando FL, 2008.

Ratings and reviews

  • Explanations the care provider gave you about your problem or condition

    4.9
  • Extent to which the care provider listened to you

    4.9
  • Care provider’s discussion of any proposed treatment (options, risks, benefits, etc.)

    4.9
  • Provider included you in decisions

    4.9
  • Concern the care provider showed for your questions or worries

    4.9
  • Likelihood of recommending this care provider to others

    4.9
  • Sep 23, 2025

    This visit was extremely helpful and gave me clear advice about a path forward, in which we have great confidence

  • Sep 11, 2025

    MD was engaging, easy to talk to, knowledgeable.

  • Sep 10, 2025

    I had every question addressed and explained to me patiently I felt like I received the best treatment and advice possible. Trust was established.